التفاصيل البيبلوغرافية
العنوان: |
Stromal lymphocytes are associated with upgrade of B3 breast lesions. |
المؤلفون: |
Kader, Tanjina, Provenzano, Elena, Jayawardana, Madawa W., Hendry, Shona, Pang, Jia-Min, Elder, Kenneth, Byrne, David J., Tjoeka, Lauren, Frazer, Helen ML., House, Eloise, Jayasinghe, Sureshni I., Keane, Holly, Murugasu, Anand, Rajan, Neeha, Miligy, Islam M., Toss, Michael, Green, Andrew R., Rakha, Emad A., Fox, Stephen B., Mann, G. Bruce |
المصدر: |
Breast Cancer Research; 7/8/2024, Vol. 26 Issue 1, p1-10, 10p |
مصطلحات موضوعية: |
LYMPHOCYTES, SURGICAL excision, DUCTAL carcinoma, TUMOR microenvironment, TUMOR-infiltrating immune cells, UNNECESSARY surgery, CARCINOMA in situ, LYMPHOCYTE count |
مستخلص: |
Various histopathological, clinical and imaging parameters have been evaluated to identify a subset of women diagnosed with lesions with uncertain malignant potential (B3 or BIRADS 3/4A lesions) who could safely be observed rather than being treated with surgical excision, with little impact on clinical practice. The primary reason for surgery is to rule out an upgrade to either ductal carcinoma in situ or invasive breast cancer, which occurs in up to 30% of patients. We hypothesised that the stromal immune microenvironment could indicate the presence of carcinoma associated with a ductal B3 lesion and that this could be detected in biopsies by counting lymphocytes as a predictive biomarker for upgrade. A higher number of lymphocytes in the surrounding specialised stroma was observed in upgraded ductal and papillary B3 lesions than non-upgraded (p < 0.01, negative binomial model, n = 307). We developed a model using lymphocytes combined with age and the type of lesion, which was predictive of upgrade with an area under the curve of 0.82 [95% confidence interval 0.77–0.87]. The model can identify some patients at risk of upgrade with high sensitivity, but with limited specificity. Assessing the tumour microenvironment including stromal lymphocytes may contribute to reducing unnecessary surgeries in the clinic, but additional predictive features are needed. [ABSTRACT FROM AUTHOR] |
|
Copyright of Breast Cancer Research is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
قاعدة البيانات: |
Complementary Index |